Glanders
APHA is a National reference laboratory for Glanders which is a contagious zoonotic bacterial disease, predominantly affecting horses, mules and donkeys. Glanders is caused by the bacterium Burkholderia mallei.
Glanders is endemic in Africa, Asia, the Middle East, and Central and South America. It has been eradicated from North America, Australia, and most of Europe through surveillance and destruction of affected animals, and import restrictions. Glanders is classified as an exotic notifiable disease in the UK, which means any suspected case must be reported to APHA by law.
Due to similar clinical features to other diseases, such as Strangles, EVA, Fungal Pneumonia, Ulcerative Lymphangitis, Pseudotuberculosis, Epizootic Lymphangitis, diagnosis of Glanders would need be confirmed by serological assay and/or specific identification of the causative agent.
The Complement Fixation Test (CFT) for Glanders is currently the only World Organisation for Animal Health (OIE) prescribed serodiagnostic method for international trade purposes and is also recommended for surveillance investigations.
Our Glanders reagents are manufactured in a dedicated Production Unit certified to ISO 9001 quality standards, and supported by expert veterinarians in our reference laboratory. To ensure consistency across different CFT kits, our products are tested against 2 common CFT antigens. For safety considerations, those antisera were raised using non-infectious materials. We recommend the use of both high and low titre positive serum to ensure sensitivity and consistency of CFT tests.
To support your laboratory with testing APHA Scientific offer the following control reagents:
RAB8678 – Glanders Equine High Positive Antiserum
Equine sera positive to Burkholderia mallei by Glanders complement fixation test. This antiserum is to be used as a high titre positive control antiserum for the Glanders CFT.
RAB8677 – Glanders Equine Low Positive Antiserum
Equine sera positive to Burkholderia mallei by Glanders complement fixation test. This antiserum is to be used as a low titre positive control antiserum for the Glanders CFT.
RAB8676 – Glanders Equine Negative Sera
Equine sera negative to Burkholderia mallei by the Glanders complement fixation test.
- Extensive expertise
- Excellent specialist facilities
- A comprehensive and quality delivery service
Meet APHA Scientific at EAVLD 2026
APHA Scientific will be attending the EAVLD 2026 Congress in Athens, connecting with veterinary diagnosticians and laboratory professionals from across Europe. Visit our team to learn more about our proficiency testing schemes, diagnostic reagents and quality assurance solutions for veterinary laboratories.
World Buiatrics Congress 2026
The World Buiatrics Congress 2026 provides a global platform for sharing knowledge on cattle health and production. APHA Scientific will be showcasing products and expertise that support the diagnosis and control of important bovine diseases.
Supporting laboratory validation with pathology control blocks
FFPE control materials are now available to support training, quality assurance and specialised laboratory testing.
APHA Science in Partnership Conference
APHA Scientific will be attending the APHA Science in Partnership Conference in York this November. The event brings together stakeholders from across science, policy and industry to explore collaboration, innovation and shared challenges.
New Salmonella Serotyping Antisera
Our Salmonella serotyping antisera portfolio is now available, supporting confirmation, serogrouping and flagellar characterisation in veterinary diagnostic laboratories.
APHA Scientific to contribute expertise at chemical and biological risk management event
APHA will join the Star Ecotronics training event APHA, including a roundtable session for direct engagement with VETQAS customers.
2026–2027 Biological Reagent Price List
New pricing for our biological reagents is now available, with updated costs applying from 1 April 2026.
AHNTI EU 2026 in London
Meet our Business Development team at AHNTI EU 2026, where 850+ leaders are shaping the future of animal health.